| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Zentalis Pharmaceuticals, Inc. (ZNTL) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 57 sells. ZNTL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.51M | $49.58M | - | |
| 10% | 6.46M | $23.71M | - | |
| Other | 146.5K | $537.7K | - | |
| Other | 100.0K | $367.0K | - | |
| CEO | 79.1K | $290.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2021 | Gallagher Cam81 | Director | Sell | 10,000 | $51.93 | $519,323.14 | -0.4% | |
| Jan 4, 2021 | Sun Anthony Y81 | President &CEO | Sell | 26,794 | $52.06 | $1,394,907.38 | -0.4% | |
| Jan 4, 2021 | Bunker Kevin D.78 | Chief Operating Officer | Sell | 34,987 | $52.05 | $1,821,116.49 | -0.8% | |
| Jan 4, 2021 | Epperly Melissa B,72 | Chief Financial Officer | Sell | 3,083 | $51.91 | $160,033.81 | -0.3% | |
| Dec 24, 2020 | Gallagher Cam81 | Director | Sell | 18,473 | $0.00 | - | -40.4% | |
| Dec 8, 2020 | Gallagher Cam81 | Director | Sell | 36,739 | $54.99 | $2,020,268.78 | -0.6% | |
| Dec 7, 2020 | Sun Anthony Y81 | President &CEO | Sell | 75,375 | $52.18 | $3,933,221.44 | -0.6% | |
| Dec 7, 2020 | Epperly Melissa B,72 | Chief Financial Officer | Sell | 13,684 | $52.18 | $714,059.90 | -0.8% | |
| Dec 7, 2020 | Bunker Kevin D.78 | Chief Operating Officer | Sell | 23,057 | $52.18 | $1,203,161.79 | -0.4% | |
| Dec 2, 2020 | Gallagher Cam81 | Director | Sell | 10,265 | $51.17 | $525,283.50 | -0.4% |